Craniopharyngioma and Eating Disorders

[1]  L. Cohen,et al.  Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma , 2020, Child's Nervous System.

[2]  B. Lapauw,et al.  Bariatric Surgery for Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy: a Matched Case–Control Study , 2020, Obesity Surgery.

[3]  T. Merchant,et al.  Craniopharyngioma , 2019, Nature Reviews Disease Primers.

[4]  A. Rah,et al.  Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review , 2019, Yearbook of Paediatric Endocrinology.

[5]  M. Warmuth-Metz,et al.  Eating behaviour and oxytocin in patients with childhood‐onset craniopharyngioma and different grades of hypothalamic involvement , 2019, Pediatric obesity.

[6]  J. Wisoff,et al.  Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma , 2019, Child's Nervous System.

[7]  Y. Schutz,et al.  European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care , 2019, Obesity Facts.

[8]  B. Lu,et al.  Endocrine and Metabolic Outcomes After Transcranial and Endoscopic Endonasal Approaches for Primary Resection of Craniopharyngiomas. , 2019, World neurosurgery.

[9]  R. Adan,et al.  Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review. , 2018, Endocrine reviews.

[10]  M. Eveslage,et al.  Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo). , 2018, European journal of endocrinology.

[11]  Weimin Ni,et al.  Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review. , 2018, World neurosurgery.

[12]  Frederick C W Wu,et al.  Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. , 2018, The Journal of clinical endocrinology and metabolism.

[13]  P. Sundgren,et al.  Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity , 2018, International Journal of Obesity.

[14]  M. Warmuth-Metz,et al.  Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007 , 2018, Endocrine.

[15]  G. Armstrong,et al.  Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Murad,et al.  Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[17]  H. Müller.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity , 2015, Current opinion in endocrinology, diabetes, and obesity.

[18]  M. Warmuth-Metz,et al.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. , 2015, Neuro-oncology.

[19]  I. Bryngelsson,et al.  Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. , 2015, The Journal of clinical endocrinology and metabolism.

[20]  A. Schembri,et al.  A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. , 2014, Pediatric neurology.

[21]  T. Merchant,et al.  Headaches in Children With Craniopharyngioma , 2013, Journal of child neurology.

[22]  J. Oppert,et al.  Clinical review: Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. , 2013, The Journal of clinical endocrinology and metabolism.

[23]  T. Tzotzas,et al.  Use of Somatostatin Analogues in Obesity , 2012, Drugs.

[24]  C. Roth.  Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits , 2011, Front. Endocrin..

[25]  C. Roth,et al.  Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity , 2011, Front. Endocrin..

[26]  R. Lustig.  Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment , 2011, Front. Endocrin..

[27]  H. Müller.  Consequences of craniopharyngioma surgery in children. , 2011, The Journal of clinical endocrinology and metabolism.

[28]  C. Roth,et al.  Appetite‐Regulating Hormone Changes in Patients With Craniopharyngioma , 2011, Obesity.

[29]  J. Honegger,et al.  Craniopharyngioma surgery , 2008, Pituitary.

[30]  S. Puget,et al.  Craniopharyngioma , 2007, Orphanet journal of rare diseases.

[31]  R. Lustig.  Autonomic Dysfunction of the β-Cell and the Pathogenesis of Obesity , 2003, Reviews in Endocrine and Metabolic Disorders.

[32]  C. Roth,et al.  Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  H. Müller,et al.  Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.